Alleviation of Depression by glucagon-like peptide 1 Through the regulation of neuroinflammation, neurotransmitters, neurogenesis, and synaptic function
Brighten breaks down how perimenopause and menopause shift insulin sensitivity, fat distribution, appetite, and recovery and where glucagon-like peptide-1 (GLP-1) receptor agonists (think semaglutide/Ozempic, Wegovy, liraglutide, tirzepatide as a related incretin therapy) can fit safely alongside hormone therapy, lifting, protein, and smart lab work
Nausea, diarrhea, constipation, and vomiting are among those that can occur during the first four to five months of use, which is when people escalate their doses, he says
What finally worked was HRT and semaglutide together
Using insulin syringes (29-31 gauge), the peptide is injected into the fat layer beneath the skin